Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Treleaven

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Journal of Hematotherapy|January 1, 1992
Bone marrow and peripheral blood stem cell harvestingJ G Treleaven, J Mehta
Hematological Oncology|January 1, 1985
Removal of tumour cells from bone marrow: an evaluation of the available techniquesJ G Treleaven, J T Kemshead
British Journal of Hospital Medicine|April 1, 1990
Immunosuppressive agents in current useJ G Treleaven, A J Barrett
Clinical and Laboratory Haematology|January 1, 1984
An evaluation of some of the methods currently available for the production of leucocyte-poor bloodJ G Treleaven, M McGregor, J Blagdon
Clinical and Laboratory Haematology|January 1, 1988
Marrow fibrosis in myeloma: improvement by alkylating agent therapyK G Patterson, J G Treleaven, A Zuiable
Journal of Clinical Pathology|June 1, 1982
Comparative study of the fenwal and pall microaggregate filters used for the production of leucocyte-poor bloodJ G Treleaven, K G Patterson, J Blagdon
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1988
Allogeneic bone marrow transplantation: current statusJ G Treleaven, A Zuiable, A Lakhani, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 1, 1986
Bone marrow harvesting for malignant diseaseJ A Maitland, J G Treleaven, H M Clink
European Journal of Nuclear Medicine|February 7, 2001
Blood transfusions and blood sampling during red blood cell mean life span determinationsT A Smith, J G Treleaven, V R McCready
Clinical and Laboratory Haematology|February 15, 2000
Delayed haemolytic transfusion reaction caused by anti-M antibody in a patient receiving interleukin-2 and interferon for metastatic renal cell cancerN Parry-Jones, M E Gore, J Taylor, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal of Hematotherapy|January 1, 1992
Bone marrow and peripheral blood stem cell harvestingJ G Treleaven, J Mehta
Hematological Oncology|January 1, 1985
Removal of tumour cells from bone marrow: an evaluation of the available techniquesJ G Treleaven, J T Kemshead
British Journal of Hospital Medicine|April 1, 1990
Immunosuppressive agents in current useJ G Treleaven, A J Barrett
Clinical and Laboratory Haematology|January 1, 1984
An evaluation of some of the methods currently available for the production of leucocyte-poor bloodJ G Treleaven, M McGregor, J Blagdon
Clinical and Laboratory Haematology|January 1, 1988
Marrow fibrosis in myeloma: improvement by alkylating agent therapyK G Patterson, J G Treleaven, A Zuiable
Journal of Clinical Pathology|June 1, 1982
Comparative study of the fenwal and pall microaggregate filters used for the production of leucocyte-poor bloodJ G Treleaven, K G Patterson, J Blagdon
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1988
Allogeneic bone marrow transplantation: current statusJ G Treleaven, A Zuiable, A Lakhani, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 1, 1986
Bone marrow harvesting for malignant diseaseJ A Maitland, J G Treleaven, H M Clink
European Journal of Nuclear Medicine|February 7, 2001
Blood transfusions and blood sampling during red blood cell mean life span determinationsT A Smith, J G Treleaven, V R McCready
Clinical and Laboratory Haematology|February 15, 2000
Delayed haemolytic transfusion reaction caused by anti-M antibody in a patient receiving interleukin-2 and interferon for metastatic renal cell cancerN Parry-Jones, M E Gore, J Taylor, et al.
Pageof 5